Vitro Biopharma, Inc. Quarterly Accrued Liabilities, Current in USD from Q3 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary
Vitro Biopharma, Inc. quarterly Accrued Liabilities, Current history and growth rate from Q3 2010 to Q2 2024.
  • Vitro Biopharma, Inc. Accrued Liabilities, Current for the quarter ending July 31, 2024 was $1.6M.
Accrued Liabilities, Current, Quarterly (USD)
Accrued Liabilities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $1.6M Jul 31, 2024 10-Q 2024-09-16
Q1 2024 $1.55M +$592K +61.8% Apr 30, 2024 10-Q 2024-05-31
Q4 2023 $1.51M +$593K +65% Jan 31, 2024 10-Q 2024-03-14
Q3 2023 $1.31M +$371K +39.5% Oct 31, 2023 10-Q 2024-09-16
Q1 2023 $959K Apr 30, 2023 10-Q 2023-06-13
Q4 2022 $913K Jan 31, 2023 10-Q 2023-03-14
Q3 2022 $940K Oct 31, 2022 10-Q 2023-06-13
Q2 2012 $2.4K -$4.35K -64.5% Jul 31, 2012 10-Q/A 2012-10-17
Q1 2012 $8.31K Apr 30, 2012 10-Q/A 2012-06-22
Q4 2011 $10.5K Jan 31, 2012 10-Q 2012-03-21
Q3 2011 $2.9K -$5.69K -66.2% Oct 31, 2011 10-K 2013-02-12
Q2 2011 $6.75K Jul 31, 2011 10-Q/A 2011-10-12
Q3 2010 $8.59K Oct 31, 2010 10-K/A 2012-02-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.